Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Sacituzumab Govitecan in People With Mesothelioma

Phase 2

Recruiting

Conditions: Mesothelioma
Mesotheliomas Pleural
Mesothelioma; Pleura

Interventions: Drug: Sacituzumab govitecan-hziy

First Posted Date: 2024-06-27

Last Posted Date: 2025-05-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT06477419

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 4 locations

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: Tinengotinib
Drug: abiraterone acetate with prednisone
Drug: Enzalutamide

First Posted Date: 2024-06-13

Last Posted Date: 2025-05-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT06457919

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 8 locations

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

Recruiting

Conditions: Neuroendocrine Tumors

Interventions: Diagnostic Test: positron emission tomography (PET) scans

First Posted Date: 2024-06-07

Last Posted Date: 2025-05-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT06448208

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Emapalumab for Pediatric Aplastic Anemia

Phase 2

Recruiting

Conditions: Aplastic Anemia
Hypocellular Marrow
Cytopenia

Interventions: Biological: Emapalumab

First Posted Date: 2024-05-28

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT06430788

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Cincinnati Children's Hospital Medical Center (Data collection only), Cincinnati, Ohio, United States
🇺🇸
Children's Hospital of Philadelphia (Data Collection AND Specimen Analysis), Philadelphia, Pennsylvania, United States

and more 2 locations

A Registry for People With Lung Cancer

Recruiting

Conditions: Lung Cancer
Lung Cancer Stage I

Interventions: Other: Patient-Reported Outcomes Measurement Information System

First Posted Date: 2024-05-22

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 600

Registration Number: NCT06424327

Locations: 🇺🇸
University of Michigan (Data Collection Only), Ann Arbor, Michigan, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 5 locations

Ulixertinib in People With Histiocytic Neoplasms

Phase 2

Recruiting

Conditions: Histiocytic Neoplasms

Interventions: Drug: Ulixertinib

First Posted Date: 2024-05-13

Last Posted Date: 2024-10-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT06411821

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States

and more 4 locations

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

Phase 2

Recruiting

Conditions: Low-Grade Serous Ovarian Cancer

Interventions: Drug: Avutometinib
Drug: Defactinib
Drug: Letrozole

First Posted Date: 2024-05-01

Last Posted Date: 2025-05-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT06394804

Locations: 🇺🇸
Emory Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 5 locations

A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Phase 2

Recruiting

Conditions: Hodgkin Lymphoma

Interventions: Drug: Brentuximab vedotin
Drug: Doxorubicin
Drug: Vinblastine
Drug: Dacarbazine
Drug: Pembrolizumab
Drug: Gemcitabine
Drug: Vinorelbine
Diagnostic Test: FDG-PET/CT scan

First Posted Date: 2024-04-22

Last Posted Date: 2025-04-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 71

Registration Number: NCT06377566

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 5 locations

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)

Early Phase 1

Recruiting

Conditions: HPV16+ Squamous Cell Carcinoma

Interventions: Drug: HB-200

First Posted Date: 2024-04-18

Last Posted Date: 2025-03-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT06373380

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York, United States

and more 4 locations

A Study Collecting Health Information to Understand and Prevent Gastric Cancer

Recruiting

Conditions: Gastric Intestinal Metaplasia
Gastric Adenocarcinoma
Gastric Cancer
Gastric Atrophy
Dysplasia

Interventions: Behavioral: Questionnaire

First Posted Date: 2024-04-17

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3200

Registration Number: NCT06370143

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy